Use of recombinant human erythropoietin to avoid blood transfusion in a Jehovah's Witness requiring hemispherectomy
- 1 October 1993
- journal article
- case report
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 79 (4) , 600-602
- https://doi.org/10.3171/jns.1993.79.4.0600
Abstract
The use of perioperative human recombinant erythropoietin is described in a Jehovah's Witness patient. Despite significant anemia, the child's hematocrit was sufficiently increased by the use of erythropoietin so that a two-stage hemispherectomy could be performed without blood transfusion.Keywords
This publication has 19 references indexed in Scilit:
- Preoperative erythropoietin in Jehovah's Witnesses who require cardiac proceduresThe Annals of Thoracic Surgery, 1991
- Recombinant human erythropoietin for a Jehovah's witness with anemia of thermal injuryAmerican Journal of Hematology, 1991
- The use of erythropoietin in a Jehovah's Witness undergoing major surgery and chemotherapyBritish Journal of Cancer, 1991
- Erythropoietin for Anemia in Jehovah's WitnessesAnnals of Internal Medicine, 1990
- Increased Preoperative Collection of Autologous Blood with Recombinant Human Erythropoietin TherapyNew England Journal of Medicine, 1989
- Treatment of the Anemia of Progressive Renal Failure with Recombinant Human ErythropoietinNew England Journal of Medicine, 1989
- Recombinant Human Erythropoietin: Implications for NephrologyAmerican Journal of Kidney Diseases, 1988
- Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis.BMJ, 1987
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- Characterization and Biological Effects of Recombinant Human ErythropoietinImmunobiology, 1986